Daniel Present
New York, New York 10029
0 studies enrolling now · 3 studies all time
What they study most
Crohn's Disease
Studies at this site
Remission in Subjects With Crohn's Disease, 1 Year Phase
— Completed
Remission in Subjects With Crohn's Disease, Open Label Extension
— Completed
A Study of the Human Anti-TNF Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease
— Completed